Notify me when Endurant Capital Management LP files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | $0 | -$17,441,623 | -$17,441,623 | 13F-HR | 07 May 2024, 11:09 | |
| Q4 2023 | 25 | $17,441,623 | +$5,692,797 | -$104,470,134 | -$98,777,337 | BSX, TMO, AXNX, ELV, ICLR | 13F-HR | 14 Feb 2024, 16:01 |
| Q3 2023 | 43 | $111,347,011 | +$81,404,066 | -$44,792,821 | +$36,611,245 | BMRN, TMO, BRKR, AZN, ELV | 13F-HR | 14 Nov 2023, 16:01 |
| Q2 2023 | 30 | $77,586,085 | +$24,232,840 | -$142,982,459 | -$118,749,619 | LH, CI, MRK, A, THC | 13F-HR | 14 Aug 2023, 16:00 |
| Q1 2023 | 49 | $194,666,407 | +$100,814,341 | -$149,637,993 | -$48,823,652 | BMRN, BDX, ELV, SBRA, LH | 13F-HR | 15 May 2023, 16:02 |
| Q4 2022 | 55 | $246,253,014 | +$80,967,440 | -$146,645,883 | -$65,678,443 | INVACARE CORP, LH, CI, MRK, CNC | 13F-HR | 14 Feb 2023, 16:01 |
| Q3 2022 | 49 | $307,049,000 | +$140,853,717 | -$82,784,089 | +$58,069,628 | INVACARE CORP, LH, HUM, TAK, BAX | 13F-HR | 14 Nov 2022, 16:03 |
| Q2 2022 | 47 | $262,192,000 | +$93,818,727 | -$144,731,988 | -$50,913,261 | INVACARE CORP, QGEN, BSX, AVTR, HUM | 13F-HR | 15 Aug 2022, 16:09 |
| Q1 2022 | 60 | $331,322,000 | +$124,045,567 | -$141,730,235 | -$17,684,668 | INVACARE CORP, CNC, LH, AZN, BMY | 13F-HR | 16 May 2022, 16:01 |
| Q4 2021 | 64 | $369,846,000 | +$214,533,943 | -$180,180,484 | +$34,353,459 | INVACARE CORP, SNY, LH, AZN, SIBN | 13F-HR | 14 Feb 2022, 16:00 |
| Q3 2021 | 51 | $328,678,000 | +$159,030,895 | -$176,118,134 | -$17,087,239 | INVACARE CORP, ABBV, HUM, JNJ, HOLX | 13F-HR | 15 Nov 2021, 16:01 |
| Q2 2021 | 57 | $363,842,000 | +$190,554,059 | -$184,871,796 | +$5,682,263 | INVACARE CORP, LH, CI, ICLR, TMO | Restatement | 27 Aug 2021, 11:44 |
| Q1 2021 | 60 | $368,298,000 | +$195,269,477 | -$134,538,961 | +$60,730,516 | KIDS, INVACARE CORP, BMY, AHCO, SNY | 13F-HR | 17 May 2021, 15:49 |
| Q4 2020 | 52 | $277,286,000 | +$107,861,845 | -$179,674,901 | -$71,813,056 | OXFD, BDX, BMY, TRILLIUM THERAPEUTICS INC, ABBV | 13F-HR | 16 Feb 2021, 15:14 |
| Q3 2020 | 57 | $289,530,000 | +$144,860,481 | -$107,061,614 | +$37,798,867 | BMY, OXFD, EHC, ABBV, IART | 13F-HR | 16 Nov 2020, 16:11 |
| Q2 2020 | 54 | $245,145,000 | +$117,636,760 | -$133,919,924 | -$16,283,164 | OXFD, EVOLENT HEALTH INC, SIBN, JNJ, CNC | 13F-HR | 14 Aug 2020, 16:13 |
| Q1 2020 | 51 | $220,672,000 | +$120,264,294 | -$149,875,433 | -$29,611,139 | SNY, PFE, HOLX, SIBN, OXFD | 13F-HR | 15 May 2020, 16:03 |
| Q4 2019 | 51 | $301,967,945 | +$149,382,650 | -$1,620,974,112 | -$1,471,591,462 | BMY, ELV, ZBH, OXFD, COR | 13F-HR | 14 Feb 2020, 16:06 |
| Q3 2019 | 48 | $251,024,000 | +$129,433,656 | -$112,395,474 | +$17,038,182 | RCM, ZBH, HCA, OXFD, LH | Restatement | 25 Nov 2019, 16:37 |
| Q2 2019 | 50 | $253,641,000 | +$127,861,502 | -$109,365,381 | +$18,496,121 | TAK, LH, ZBH, WMGI, RCM | 13F-HR | 14 Aug 2019, 16:07 |
| Q1 2019 | 65 | $235,341,000 | +$161,929,504 | -$126,461,252 | +$35,468,252 | BMY, IIN, ICLR, VCRA, CI | 13F-HR | 15 May 2019, 16:05 |
| Q4 2018 | 48 | $189,197,000 | +$94,388,145 | -$105,930,621 | -$11,542,476 | AGN, CI, ZBH, CELG, CVS | 13F-HR | 14 Feb 2019, 16:04 |
| Q3 2018 | 73 | $224,793,000 | +$85,770,335 | -$115,124,438 | -$29,354,103 | CI, SHPG, AGN, TVTY, WMGI | 13F-HR | 14 Nov 2018, 16:07 |
| Q2 2018 | 65 | $230,616,000 | +$55,190,993 | -$104,872,360 | -$49,681,367 | AGN, MRK, ABT, SHPG, CI | 13F-HR | 14 Aug 2018, 16:09 |
| Q1 2018 | 69 | $267,700,000 | +$91,249,501 | -$143,331,784 | -$52,082,283 | AGN, ABT, JNJ, MDT, BDX | 13F-HR | 15 May 2018, 16:06 |
| Q4 2017 | 75 | $327,171,000 | +$113,253,451 | -$119,470,775 | -$6,217,324 | DVA, WBA, AGN, SBRA, MCK | 13F-HR | 14 Feb 2018, 16:16 |
| Q3 2017 | 84 | $326,131,000 | +$103,851,242 | -$132,767,087 | -$28,915,845 | DVA, BIIB, OXFD, SBRA, DHR | 13F-HR | 14 Nov 2017, 16:21 |
| Q2 2017 | 92 | $353,664,000 | +$115,556,116 | -$90,268,558 | +$25,287,558 | TMO, UHS, OXFD, ABT, DVA | 13F-HR | 14 Aug 2017, 16:32 |
| Q1 2017 | 88 | $311,018,000 | +$123,735,527 | -$75,278,509 | +$48,457,018 | ABT, BDX, UHS, SHPG, DVA | 13F-HR | 15 May 2017, 16:39 |
| Q4 2016 | 73 | $242,000,000 | +$66,797,416 | -$81,345,543 | -$14,548,127 | SHPG, HLS, STJ, ABT, UNH | 13F-HR | 14 Feb 2017, 17:49 |
| Q3 2016 | 96 | $269,800,000 | +$62,804,216 | -$107,859,435 | -$45,055,219 | SHPG, AGN, ABT, AMSG, HLS | 13F-HR | 14 Nov 2016, 18:08 |
| Q2 2016 | 88 | $299,166,000 | +$85,043,967 | -$113,510,331 | -$28,466,364 | AGN, SHPG, MNKKQ, HLS, MCK | 13F-HR | 15 Aug 2016, 16:38 |
| Q1 2016 | 86 | $308,678,000 | +$83,556,665 | -$49,567,785 | +$33,988,880 | TEVA, MNKKQ, HLS, AET, HRC | 13F-HR | 16 May 2016, 17:13 |
| Q4 2015 | 77 | $299,039,000 | +$89,898,859 | -$118,349,590 | -$28,450,731 | TEVA, MNKKQ, ZBH, HLS, MDT | 13F-HR | 16 Feb 2016, 17:06 |
| Q3 2015 | 77 | $299,508,000 | +$107,557,041 | -$107,924,250 | -$367,209 | STJ, TMO, BDX, TEVA, AGN | 13F-HR | 16 Nov 2015, 17:15 |
| Q2 2015 | 93 | $338,867,000 | +$137,666,211 | -$108,302,385 | +$29,363,826 | BDX, AGN, LH, TMO, GMED | 13F-HR | 14 Aug 2015, 17:17 |
| Q1 2015 | 96 | $302,675,000 | +$112,456,709 | -$90,503,280 | +$21,953,429 | GMED, B108PS, TMO, BDX, TEVA | 13F-HR | 15 May 2015, 16:53 |
| Q4 2014 | 87 | $254,880,000 | $0 | $0 | $0 | TMO, BDX, B108PS, UHS, ELV | 13F-HR | 13 Feb 2015, 20:05 |